New Therapy Shows Promise For PIK3CA-Related Overgrowth Spectrum in Retrospective Study
Data has recently been announced from a study investigating the efficacy of a new therapy called Alpelisib, for the treatment of PIK3CA-related overgrowth spectrum (PROS). The study was called EPIK-P1.…